BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 15183644)

  • 1. Does thalidomide have a role in leprosy?
    Crawford CL
    Lancet; 2004 Jun; 363(9424):1911. PubMed ID: 15183644
    [No Abstract]   [Full Text] [Related]  

  • 2. No role for thalidomide in the treatment of leprosy.
    Crawford CL
    J Infect Dis; 2006 Jun; 193(12):1743-4; author reply 1744-5. PubMed ID: 16703522
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of erythema nodosum leprosum using thalidomide].
    Sheskin J
    Acta Leprol; 1983; 1(1):41-50. PubMed ID: 6401140
    [No Abstract]   [Full Text] [Related]  

  • 4. Preparing for thalidomide's comeback.
    Vanchieri C
    Ann Intern Med; 1997 Nov; 127(10):951-2. PubMed ID: 9446509
    [No Abstract]   [Full Text] [Related]  

  • 5. Concerns regarding in vitro and in vivo uses of thalidomide.
    Tadesse A; Shannon EJ
    Lepr Rev; 2005 Mar; 76(1):94-6. PubMed ID: 15881041
    [No Abstract]   [Full Text] [Related]  

  • 6. The schizophrenic career of a "monster drug".
    Crawford CL
    Pediatrics; 2003 Mar; 111(3):712. PubMed ID: 12612270
    [No Abstract]   [Full Text] [Related]  

  • 7. [Thalidomide used by patients with erythema nodosum leprosum].
    Valente Mdo S; Vieira JL
    Rev Soc Bras Med Trop; 2010; 43(2):201-4. PubMed ID: 20464154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dependent thalidomide induced bradycardia in young erythema nodosum leprosum patient.
    Thangaraju P; Venkatesan S; Sivashanmugam E; Showkath Ali MK
    Indian J Pharmacol; 2019; 51(1):72-74. PubMed ID: 31031470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide in the treatment of leprosy.
    Teo S; Resztak KE; Scheffler MA; Kook KA; Zeldis JB; Stirling DI; Thomas SD
    Microbes Infect; 2002 Sep; 4(11):1193-202. PubMed ID: 12361920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep vein thrombosis in a patient with lepromatous leprosy receiving thalidomide to treat leprosy reaction.
    Hebe Petiti-Martin G; Villar-Buill M; de la Hera I; Fuertes L; Burgués-Calderón M; Rivera-Díaz R; Vanaclocha F
    Actas Dermosifiliogr; 2013 Jan; 104(1):67-70. PubMed ID: 22705284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1998 Sep; 280(10):872. PubMed ID: 9739956
    [No Abstract]   [Full Text] [Related]  

  • 12. Deep vein thrombosis: a rare complication of thalidomide therapy in recurrent erythema nodosum leprosum.
    Sharma NL; Sharma V; Shanker V; Mahajan VK; Sarin S
    Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):483-5. PubMed ID: 15755204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral edema in lepromatous leprosy--could thalidomide be the culprit.
    Mehta V
    Indian J Lepr; 2008; 80(4):345-6. PubMed ID: 20329383
    [No Abstract]   [Full Text] [Related]  

  • 14. Thalidomide in the treatment of erythema nodosum leprosum (ENL) in an outpatient setting: A five-year retrospective analysis from a leprosy referral centre in India.
    Upputuri B; Pallapati MS; Tarwater P; Srikantam A
    PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008678. PubMed ID: 33035210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The management of erythema nodosum leprosum: current and future options.
    Lockwood DN
    Lepr Rev; 1996 Dec; 67(4):253-9. PubMed ID: 9033196
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinicopathologic challenge.
    Kawakami T; Tsutsumi Y; Mizoguchi M; Ishi N; Soma Y
    Int J Dermatol; 2007 Apr; 46(4):348-9. PubMed ID: 17442070
    [No Abstract]   [Full Text] [Related]  

  • 17. Frequency of thromboembolic events associated with thalidomide in the non-cancer setting: a case report and review of the literature.
    Fabi SG; Hill C; Witherspoon JN; Boone SL; West DP
    J Drugs Dermatol; 2009 Aug; 8(8):765-9. PubMed ID: 19663116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thalidomide: new uses for an old drug].
    Wu KL; Sonneveld P
    Ned Tijdschr Geneeskd; 2002 Aug; 146(31):1438-41. PubMed ID: 12190008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind trial of the efficacy of pentoxifylline vs thalidomide for the treatment of type II reaction in leprosy.
    Sales AM; de Matos HJ; Nery JA; Duppre NC; Sampaio EP; Sarno EN
    Braz J Med Biol Res; 2007 Feb; 40(2):243-8. PubMed ID: 17273661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bangkok Workshop on Leprosy Research. Treatment of reactions and nerve damage.
    Naafs B
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4 Suppl):S21-8. PubMed ID: 9030120
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.